NIH Guide: Weekly Index for November 8, 2024

Funding Opportunities

• Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
  (PA-25-172)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
  (PA-25-253)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
  (PAR-24-306)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
  (PAR-24-311)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
  (PAR-24-321)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
  (PAR-24-325)
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Aging
  National Cancer Institute
  National Eye Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)
  (PAR-25-027)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.
• Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
  (PAR-25-036)
  National Institute of Mental Health
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)
  (PAR-25-049)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
• Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)
  (PAR-25-063)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
  (PAR-25-079)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Co-infection and Cancer (R01 Clinical Trial Not Allowed)
  (PAR-25-082)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Co-infection and Cancer (R21 Clinical Trial Not Allowed)
  (PAR-25-083)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
  (PAR-25-103)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
  (PAR-25-104)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
  (PAR-25-106)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)
  (PAR-25-107)
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): February 05, 2025
• Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)
  (PAR-25-108)
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): February 16, 2025
• Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
  (PAR-25-117)
  National Institute of General Medical Sciences
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Multiple dates, see announcement.
• Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
  (PAR-25-136)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
  (PAR-25-139)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)
  (PAR-25-140)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Dental and Craniofacial Research
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
  (PAR-25-145)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)
  (PAR-25-146)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
• Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
  (PAR-25-153)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
  (PAR-25-175)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)
  (PAR-25-186)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2025
• Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed)
  (PAR-25-198)
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed)
  (PAR-25-199)
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Integrating Mental Health Care into Health Care Systems and Non-Health Settings in Low- and Middle-Income Countries (R01 Clinical Trial Optional)
  (PAR-25-201)
  National Institute of Mental Health
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
  (PAR-25-218)
  National Institute on Aging
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
  (PAR-25-219)
  National Institute on Aging
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
  (PAR-25-221)
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Multiple dates, see announcement.
• NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
  (PAR-25-222)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
  (PAR-25-225)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
• Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
  (PAR-25-227)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
• NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
  (PAR-25-234)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
• Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
  (PAR-25-235)
  National Library of Medicine
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
  (PAR-25-237)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
  (PAS-25-190)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Eye Institute
  National Human Genome Research Institute
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
  (PAS-25-205)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute on Aging
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Combating Antibiotic-Resistant Bacteria Interdisciplinary Research Units (CARBIRUs) (P01 Clinical Trial Not Allowed)
  (RFA-AI-24-074)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): March 26, 2025
• Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R43/R44 - Clinical Trials Optional)
  (RFA-DA-26-018)
  National Institute on Drug Abuse
  Application Receipt Date(s): Not Applicable
• Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R41/R42 - Clinical Trials Optional)
  (RFA-DA-26-019)
  National Institute on Drug Abuse
  Application Receipt Date(s): February 19, 2025
• Engaging Loved ones in Recovery Processes to Enhance Recovery Capital and Outcomes (R61/R33 Clinical Trial Optional)
  (RFA-DA-26-024)
  National Institute on Drug Abuse
  Application Receipt Date(s): February 27, 2025
• BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
  (RFA-NS-25-021)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
  (RFA-NS-25-022)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition: Continued Development of INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project Data Coordinating Center (U2C Clinical Trial Not Allowed)
  (RFA-OD-25-002)
  Office of the Director, NIH
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Not Applicable